Anti-GCGR Antibody (Crotedumab)
Catalog No.
F1109
Anti-GCGR Antibody (Crotedumab)
Featured Products
Crotedumab (REGN1193) is a humanized IgG4 monoclonal antibody that binds to and inhibits the glucagon receptor (GCGR) with a KD of 0.1 nM. Crotedumab can be used in diabetes research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.82 kDa
Dry ice
1452387-69-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
REGN1193
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P47871
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human GCCR His EGFP HEK293 cells were stained with Anti-GCGR Antibody (Crotedumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
GCGR
Please avoid freeze-thaw cycles.